Importer of Controlled Substances; Notice of Application; Noramco, Inc., 3627 [2014-01157]
Download as PDF
<![CDATA[
3627
Federal Register / Vol. 79, No. 14 / Wednesday, January 22, 2014 / Notices
for such registration pursuant to
21.U.S.C. 958(a); 21 U.S.C. 823(a); and
21 CFR 1301.34(b), (c), (d), (e), and (f)
are satisfied.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application; Noramco, Inc.
Pursuant to 21 CFR 1301.34 (a), this
is notice that on December 3, 2013,
Noramco, Inc., 1440 Olympic Drive,
Athens, Georgia 30601, made
application by renewal to the Drug
Enforcement Administration (DEA) for
registration as an importer of the basic
classes of controlled substances:
emcdonald on DSK67QTVN1PROD with NOTICES
Phenylacetone (8501) ..................
Thebaine (9333) ...........................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
BILLING CODE 4410–09–P
Dated: January 14, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
DEPARTMENT OF JUSTICE
[FR Doc. 2014–01156 Filed 1–21–14; 8:45 am]
Schedule
Drug
Drug Enforcement Administration
BILLING CODE 4410–09–P
II
II
II
II
Importer of Controlled Substances;
Notice of Registration; Noramco, Inc.
DEPARTMENT OF JUSTICE
By Notice dated September 27, 2013,
and published in the Federal Register
on October 25, 2013, 78 FR 64015,
Noramco, Inc., 500 Swedes Landing
Road, Wilmington, Delaware 19801–
4417, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
the following basic classes of controlled
substances:
Drug Enforcement Administration
The company plans to import the
listed controlled substances to
manufacture other controlled substances
for distribution to the company’s
customers.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007)
In reference to the non-narcotic raw
material, any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedules I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act (21 U.S.C.
952(a)(2)(B)) may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43, and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODW), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than February 21, 2014.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745–46, all applicants for
registration to import a basic class of
any controlled substances in schedules
I or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
VerDate Mar<15>2010
16:00 Jan 21, 2014
Dated: January 14, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Jkt 232001
[FR Doc. 2014–01157 Filed 1–21–14; 8:45 am]
Drug
Schedule
Phenylacetone (8501) ..................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
II
II
II
II
The company plans to import the
Opium, raw (9600) and Poppy Straw
Concentrate (9670) to manufacture other
controlled substances. The company
plans to import Tapentadol (9780) in
intermediate form for the bulk
manufacture of Tapentadol (9780) for
distribution to its customers. The
company plans to import Phenylacetone
(8501) in bulk for the manufacture of a
controlled substance.
Comments and requests for hearings
on application to import narcotic raw
material are not appropriate. 72 FR 3417
(2007)
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Noramco, Inc., to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Noramco, Inc., to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Manufacturer of Controlled
Substances, Notice of Application:
Noramco, Inc.
Pursuant to 21 CFR 1301.33(a), this is
notice that on August 5, 2013, Noramco,
Inc., 500 Swedes Landing Road,
Wilmington, Delaware 19801–4417,
made application by renewal to the
Drug Enforcement Administration
(DEA) as a bulk manufacturer of the
following basic classes of controlled
substances:
Drug
Codeine-N-oxide (9053) ...............
Dihydromorphine (9145) ...............
Morphine-N-oxide (9307) .............
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Phenylacetone (8501) ..................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Opium extracts (9610) ..................
Opium fluid extract (9620) ............
Opium tincture (9630) ..................
Opium, powdered (9639) .............
Opium, granulated (9640) ............
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Tapentadol (9780) ........................
Schedule
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
E:\FR\FM\22JAN1.SGM
22JAN1
]]>Agencies
[Federal Register Volume 79, Number 14 (Wednesday, January 22, 2014)]
[Notices]
[Page 3627]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01157]
[[Page 3627]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application;
Noramco, Inc.
Pursuant to 21 CFR 1301.34 (a), this is notice that on December 3,
2013, Noramco, Inc., 1440 Olympic Drive, Athens, Georgia 30601, made
application by renewal to the Drug Enforcement Administration (DEA) for
registration as an importer of the basic classes of controlled
substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Phenylacetone (8501)....................... II
Thebaine (9333)............................ II
Poppy Straw Concentrate (9670)............. II
Tapentadol (9780).......................... II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture other controlled substances for distribution to the
company's customers.
Comments and requests for hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417 (2007)
In reference to the non-narcotic raw material, any bulk
manufacturer who is presently, or is applying to be, registered with
DEA to manufacture such basic classes of controlled substances listed
in schedules I or II, which fall under the authority of section
1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in the
circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43, and in such form as prescribed by 21 CFR
1316.47.
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODW), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than February 21, 2014.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, 40 FR 43745-46, all applicants
for registration to import a basic class of any controlled substances
in schedules I or II are, and will continue to be, required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21.U.S.C. 958(a); 21 U.S.C. 823(a); and
21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: January 14, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2014-01157 Filed 1-21-14; 8:45 am]
BILLING CODE 4410-09-P
